What changed
China has issued a new opinion making enterprises the main actors in developing “new quality productive forces.” It gives companies a larger role in innovation decisions, investment, research organisation, national technology projects and turning discoveries into products.
The policy’s starting point is already substantial:
- Enterprises account for more than 75% of China’s total research spending, a share maintained for several consecutive years.
- China had 504,000 high-tech enterprises at the end of 2025, more than 80% above 2020.
- Companies in the 2026 ranking of China’s top 500 private enterprises reported 1.26 trillion yuan in research spending.
Why it matters
This shifts the centre of gravity in China’s innovation system closer to the market. Companies are expected to identify demand, decide where research money goes and help judge whether results are useful. In practical terms, the policy is designed to shorten the distance between a laboratory breakthrough and something that can actually be used.
The government is not stepping away. It will continue strategic planning, major technology programmes and national innovation platforms. But the opinion also draws a boundary around that role: local governments should provide conditions and services, not chase fashionable industries with indiscriminate subsidies, duplicate construction or projects chosen on behalf of the market.
That tension will decide whether the policy delivers. China already has a large and growing corporate research base. The harder test is whether public support becomes predictable enough for companies to take long-term risks, while competition still determines which technologies survive. Implementation schedules, eligibility rules and the scale of fiscal and financial support have not yet been specified, so the policy’s effect on innovation productivity and regional investment remains to be demonstrated.
Comments
No comments yet.